Daiichi Industrial Pharmaceutical plans to dispose of 1,792 common shares at 13,200 yen each on July 15, 2026, and will introduce a restricted stock compensation system. The scheme sets a one-year restriction period for the targeted directors.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4461","jir_company_name":"Daiichi Industrial Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-06-23","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4461-20260623-01.pdf","jir_short_summary":"Daiichi Industrial Pharmaceutical plans to dispose of 1,792 common shares at 13,200 yen each on July 15, 2026, and will introduce a restricted stock compensation system. The scheme sets a one-year restriction period for the targeted directors.","jir_summary":"### Overview of Capital Policy\nDaiichi Industrial Pharmaceutical will dispose of 1,792 common shares at 13,200 yen each on July 15, 2026, as part of its restricted stock compensation system. This scheme is introduced for directors and auditors to share value with shareholders. The restriction period is one year, with provisions for\u89e3\u9664 or free acquisition of shares upon dismissal or during organizational restructuring.\n\n### Future Outlook and Impact on Shareholders\nThe share disposal aims to enhance shareholder value and strengthen executive incentives. The introduction of the restricted stock scheme encourages long-term commitment to increasing corporate value and is designed to minimize shareholder dilution. The company will continue to promote its mid-term management plan, 'SMART 2030,' aiming for sustainable growth.","jir_financial_highlights":"Number of shares disposed: 1,792 shares (unknown)\nDisposal amount: 23,654,400 yen (unknown)\nRestriction period: July 15, 2026 \u2013 July 14, 2027 (unknown)","jir_category":"","jir_hashtags":"#DaiichiIndustrialPharmaceutical, #IRRelated, #JapaneseStocks","jir_key_figures":"Number of shares disposed: 1,792 shares\nDisposal amount: 23,654,400 yen\nRestriction period: July 15, 2026 \u2013 July 14, 2027","jir_meta_title":"[Daiichi Industrial Pharmaceutical] Share Buyback and Introduction of Stock Compensation System | June 2026","jir_meta_description":"Daiichi Industrial Pharmaceutical plans to dispose of 1,792 shares in July 2026 and introduce a restricted stock compensation scheme. The initiative aims to promote long-term incentives and shareholder value enhancement.","jir_og_title":"[Daiichi Industrial Pharmaceutical] Share Disposal and Compensation System Introduction | June 2026","jir_og_description":"Daiichi Industrial Pharmaceutical is implementing share disposal and a new remuneration system to enhance corporate value and strengthen long-term incentives for executives.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16712,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-67738","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n